Lifebit

Lifebit is a Data Intelligence Platform purpose-built for precision medicine, enabling health researchers, pharmaceutical organizations, government health agencies, and data providers to manage, analyze, and derive insights from large-scale patient data — without ever moving it. Operating at a scale of over 275 million patients, Lifebit's federated approach ensures that data remains in place while compute and AI workflows travel to it, eliminating the geographical, logistical, and financial barriers traditionally associated with moving exceptionally large datasets.

Lifebit serves a broad range of customers across the global life sciences ecosystem, including national genomics programs, federal health agencies, academic research institutions, cancer research networks, pharmaceutical companies such as Boehringer Ingelheim, and health data non-profits. Its platform has been recognized as the number one Trusted Research Environment and has contributed to landmark outcomes including a 27% cure rate for breast cancer patients, as published in a Lancet Oncology study.

Core Platform Capabilities

• Federated Data Access with Zero Data Movement: Lifebit's foundational architecture ensures that patient data stays in place at all times. Compute jobs and AI models are dispatched to the data, not the other way around, enabling compliant cross-border and cross-institution research without data transfer risk.
• Instant Federation: Distributed datasets across multiple institutions, countries, or jurisdictions can be connected and operated as a unified resource in minutes rather than years, dramatically accelerating research timelines.
• Data Transformation and Harmonisation: Lifebit provides data transformation and mapping tools that allow organizations to process and harmonize distributed data through a single centralized, auditable, and reproducible workflow — a capability validated by participants of the NLM Federated Data Workshop.
• Trusted Research Environment (TRE): The platform provides a secure, governed environment for researchers to access and analyze sensitive health and genomic data, ensuring 100% patient data security that is built in by design rather than added as an afterthought.
• Built-in Compliance: Compliance controls are embedded natively into the platform, supporting organizations operating under strict regulatory and data governance requirements across multiple national and international jurisdictions.
• AI and Analytical Workflows: Lifebit enables AI-driven discovery at scale, supporting use cases such as gene-protein target validation — reducing the time required for such tasks by up to 90% — and broader translational research from large external healthcare biobanks.

Key Use Cases and Applications

• Cancer Research: Lifebit's platform has been instrumental in powering cancer cure research, including the breast cancer Research Network study published in Lancet Oncology, and is actively used by organizations focused on reimagining cancer care infrastructure to unlock the potential of cancer data.
• Rare Disease Research: By enabling federated access to distributed datasets, Lifebit opens new avenues for rare disease discovery where data scarcity and geographic fragmentation have historically been major obstacles.
• National and Federal Health Programs: Lifebit powers health discovery initiatives across the United Kingdom, Canada, Singapore, and the United States federal government, supporting national-scale genomic and clinical data programs.
• Pharmaceutical Drug Discovery: Pharma organizations use Lifebit to capture translational disease insights from large external healthcare biobanks, accelerating the development of innovative medicines and reducing time to validate gene-protein targets.
• Clinico-Genomic Precision Medicine: In collaboration with partners such as Synapxe in Singapore, Lifebit advances the use of clinico-genomic data for precision medicine, supporting translation into clinical workflows to improve patient outcomes.
• Data Provider Enablement: Lifebit supports data providers and health non-profits in making their datasets discoverable, accessible, and actionable for the broader research community.

Notable Partnerships and Endorsements

• Genomics England — Lifebit joined Genomics England to launch the next phase of their research capabilities, as recognized by former CEO Chris Wigley.
• University of Cambridge — Professor Serena Nik-Zainal has highlighted Lifebit's potential to remove barriers to large-scale dataset research, particularly for rare diseases and health equity.
• Boehringer Ingelheim — Lifebit plays an important role in Boehringer Ingelheim's strategy to leverage large external healthcare biobanks for translational disease insights, as noted by their SVP and Global Head of Computational Biology and Digital Sciences.
• Synapxe (Singapore) — Lifebit collaborates with Synapxe to advance clinico-genomic data use for precision medicine in Singapore.
• NLM Federated Data Workshop — Consensus feedback from participants confirmed that Lifebit's tools enable data harmonization at a speed and scale previously unachievable.
• DREAM Platform — Platform administrators have endorsed Lifebit as essential for organizations seeking to maximize the impact of their data management capabilities.

Performance and Outcomes

• 27% cure rate achieved for breast cancer patients through federated research enabled by the Lifebit Platform.
• 0% data movement — all patient data remains in situ while analysis is performed remotely and securely.
• Federated data connection and harmonization completed in minutes rather than the years traditionally required.
• 90% reduction in time required to validate gene-protein targets for pharmaceutical research.
• 10x faster global data connectivity and delivery compared to conventional approaches.
• 100% user satisfaction rate, with all users consistently finding the right data and obtaining results.
• Operations at a scale exceeding 275 million patients across global health datasets.

Lifebit's mission is to make health data universally accessible and actionable for research and clinical decision-making, without compromising security, compliance, or patient privacy. By combining instant federation, built-in compliance, and zero-risk data architecture, Lifebit enables the life sciences community to accelerate discoveries that would otherwise take years — or remain impossible — under conventional data-sharing models.